Otorite, Avrupa \u0130la\u00e7 Ajans\u0131’n\u0131n (EMA) \u00e7ar\u015famba g\u00fcn\u00fc Avrupa’da \u00e7ok say\u0131da insan\u0131n u\u011frad\u0131\u011f\u0131 ola\u011fand\u0131\u015f\u0131 kan p\u0131ht\u0131lar\u0131n\u0131n AstraZeneca’n\u0131n Covid-19’unun nadir yan etkileri olarak g\u00f6r\u00fclmesi gerekti\u011fi sonucuna vard\u0131\u011f\u0131n\u0131 duyurmas\u0131n\u0131n ard\u0131ndan hen\u00fcz bir karar\u0131 kesinle\u015ftirmedi\u011fini do\u011frulad\u0131. Ancak genel olarak a\u015f\u0131n\u0131n faydalar\u0131 riskten daha a\u011f\u0131r bas\u0131yor.<\/p>\n
Danimarka Sa\u011fl\u0131k Dairesi M\u00fcd\u00fcr\u00fc S\u00f8ren Brostr\u00f8m, Danimarka’n\u0131n AstraZeneca a\u015f\u0131s\u0131n\u0131n kullan\u0131m\u0131n\u0131 durdurmak i\u00e7in ald\u0131\u011f\u0131 pozisyonu destekledi\u011fini s\u00f6yledi.<\/p>\n
“EMA\u2019n\u0131n sonucu, olas\u0131 ba\u011flant\u0131y\u0131 ara\u015ft\u0131rman\u0131n \u00f6nemli oldu\u011funu g\u00f6steriyor.\u201d dedi.<\/p>\n
Brostr\u00f8m yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, “A\u015f\u0131 ara\u015ft\u0131r\u0131l\u0131rken a\u015f\u0131y\u0131 duraklatman\u0131n Danimarka’da makul bir ihtiyat g\u00f6sterdi\u011fimizi onaylad\u0131\u011f\u0131 ortaya \u00e7\u0131kt\u0131” dedi.<\/p>\n
“Danimarka sonu\u00e7lar\u0131n\u0131 bekliyoruz ve ayr\u0131ca edindi\u011fimiz bilgilere dayanarak gelecek hafta bir duyuru ile gelmeyi umuyoruz” diye ekledi.<\/p>\n
Oxford \u00dcniversitesi ile geli\u015ftirilen milyonlarca a\u015f\u0131 dozu uygulan\u0131rken, az say\u0131da insan \u00f6l\u00fcmc\u00fcl kan p\u0131ht\u0131lar\u0131 geli\u015ftirdi ve bu da Danimarka’y\u0131 ve Avrupa Birli\u011fi’nin en b\u00fcy\u00fck \u00fc\u00e7 \u00fclkesi (Almanya, Fransa ve \u0130talya) dahil di\u011fer \u00fclkeleri enjeksiyonlar\u0131 ge\u00e7ici olarak ask\u0131ya almaya sevk etti.<\/p>\n
Mart ay\u0131nda EMA, a\u015f\u0131n\u0131n insanlar\u0131 Covid-19’a kar\u015f\u0131 korumada “g\u00fcvenli ve etkili” oldu\u011funu, ancak kan p\u0131ht\u0131lar\u0131 ile bir ba\u011flant\u0131y\u0131 g\u00f6z ard\u0131 edemeyece\u011fini ve daha fazla ara\u015ft\u0131rmaya ihtiya\u00e7 oldu\u011funu s\u00f6ylemi\u015fti.<\/p>\n
\u00c7ar\u015famba g\u00fcn\u00fc EMA, AstraZeneca a\u015f\u0131s\u0131n\u0131n t\u00fcm ya\u015f gruplar\u0131 i\u00e7in kullan\u0131lmaya devam etmesi gerekti\u011fini, ancak insanlara olas\u0131 nadir yan etkilerin anlat\u0131lmas\u0131n\u0131n da \u00f6nemli oldu\u011funu s\u00f6yledi. Duyuru, Birle\u015fik Krall\u0131k’\u0131n kendi uyu\u015fturucu d\u00fczenleme kurumunun AZ a\u015f\u0131s\u0131n\u0131n art\u0131k yaln\u0131zca 30’lu ya\u015flar\u0131n \u00fczerinde olmas\u0131 gerekti\u011fini s\u00f6ylemesinin ard\u0131ndan geldi.<\/p>\n
EMA, “sa\u011fl\u0131k uzmanlar\u0131na ve a\u015f\u0131y\u0131 alan ki\u015filere, a\u015f\u0131lamadan sonraki iki hafta i\u00e7inde meydana gelen d\u00fc\u015f\u00fck seviyelerde kan trombositleri ile birlikte \u00e7ok nadir g\u00f6r\u00fclen kan p\u0131ht\u0131s\u0131 vakalar\u0131n\u0131n fark\u0131nda olmaya devam etmelerini hat\u0131rlatt\u0131\u011f\u0131n\u0131” a\u00e7\u0131klad\u0131.<\/p>\n
Danimarka ba\u015flang\u0131\u00e7ta a\u015f\u0131 kullan\u0131m\u0131n\u0131 11 Mart’ta durdurmu\u015f, ard\u0131ndan ask\u0131ya alma s\u00fcresini 25 Mart’tan itibaren \u00fc\u00e7 hafta uzatm\u0131\u015ft\u0131.<\/p>\n
Danimarka Sa\u011fl\u0131k Otoritesi, planland\u0131\u011f\u0131 gibi nihai karar\u0131n\u0131 \u00f6n\u00fcm\u00fczdeki hafta a\u00e7\u0131klamay\u0131 bekliyor.<\/p>\n
Resmi rakamlara g\u00f6re, Danimarka’da 150.000’den az ki\u015fi AstraZeneca a\u015f\u0131s\u0131n\u0131 ald\u0131.<\/p>\n
Brostr\u00f8m, \u015firketin a\u015f\u0131s\u0131n\u0131 Danimarka’da alm\u0131\u015f olanlar i\u00e7in herhangi bir kan p\u0131ht\u0131s\u0131 riskinin muhtemelen art\u0131k ortadan kalkt\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
\u201cA\u015f\u0131lama ile ilgili ciddi yan etki riskinin ilk 7-10 g\u00fcn i\u00e7inde en y\u00fcksek seviyede olmas\u0131n\u0131n beklendi\u011fini, 14 g\u00fcn sonra olduk\u00e7a az oldu\u011funu ve 21 g\u00fcn sonra tamamen ortadan kalkt\u0131\u011f\u0131n\u0131 g\u00f6rebiliyoruz\u201d dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"
Otorite, Avrupa \u0130la\u00e7 Ajans\u0131’n\u0131n (EMA) \u00e7ar\u015famba g\u00fcn\u00fc Avrupa’da \u00e7ok say\u0131da insan\u0131n u\u011frad\u0131\u011f\u0131 ola\u011fand\u0131\u015f\u0131 kan p\u0131ht\u0131lar\u0131n\u0131n AstraZeneca’n\u0131n Covid-19’unun nadir yan etkileri olarak g\u00f6r\u00fclmesi gerekti\u011fi sonucuna vard\u0131\u011f\u0131n\u0131 duyurmas\u0131n\u0131n ard\u0131ndan hen\u00fcz bir karar\u0131 kesinle\u015ftirmedi\u011fini do\u011frulad\u0131. Ancak genel olarak a\u015f\u0131n\u0131n faydalar\u0131 riskten daha a\u011f\u0131r bas\u0131yor. Danimarka Sa\u011fl\u0131k Dairesi M\u00fcd\u00fcr\u00fc S\u00f8ren Brostr\u00f8m, Danimarka’n\u0131n AstraZeneca a\u015f\u0131s\u0131n\u0131n kullan\u0131m\u0131n\u0131 durdurmak i\u00e7in ald\u0131\u011f\u0131 pozisyonu […]<\/p>\n","protected":false},"author":8,"featured_media":79355,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"footnotes":""},"categories":[2],"tags":[],"coauthors":[],"class_list":["post-80132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-danimarka"],"yoast_head":"\n